Group A streptococcal disease in paediatric inpatients: a European perspective.
Group A streptococcal disease in paediatric inpatients: a European perspective.
复制标题
DOI:
10.1007/s00431-022-04718-y
复制
发表时间:
2023-02
影响因子:
3.6
通讯作者:
EUCLIDS consortium
中科院分区:
文献类型:
--
作者:
Boeddha NP;Atkins L;de Groot R;Driessen G;Hazelzet J;Zenz W;Carrol ED;Anderson ST;Martinon-Torres F;Agyeman PKA;Galassini R;Herberg J;Levin M;Schlapbach LJ;Emonts M;EUCLIDS consortium
Group A streptococcal (GAS) disease shows increasing incidence worldwide. We characterised children admitted with GAS infection to European hospitals and studied risk factors for severity and disability. This is a prospective, multicentre, cohort study (embedded in EUCLIDS and the Swiss Pediatric Sepsis Study) including 320 children, aged 1 month to 18 years, admitted with GAS infection to 41 hospitals in 6 European countries from 2012 to 2016. Demographic, clinical, microbiological and outcome data were collected. A total of 195 (61%) patients had sepsis. Two hundred thirty-six (74%) patients had GAS detected from a normally sterile site. The most common infection sites were the lower respiratory tract (LRTI) (22%), skin and soft tissue (SSTI) (23%) and bone and joint (19%). Compared to patients not admitted to PICU, patients admitted to PICU more commonly had LRTI (39 vs 8%), infection without a focus (22 vs 8%) and intracranial infection (9 vs 3%); less commonly had SSTI and bone and joint infections (p < 0.001); and were younger (median 40 (IQR 21–83) vs 56 (IQR 36–85) months, p = 0.01). Six PICU patients (2%) died. Sequelae at discharge from hospital were largely limited to patients admitted to PICU (29 vs 3%, p < 0.001; 12% overall) and included neurodisability, amputation, skin grafts, hearing loss and need for surgery. More patients were recruited in winter and spring (p < 0.001). Conclusion: In an era of observed marked reduction in vaccine-preventable infections, GAS infection requiring hospital admission is still associated with significant severe disease in younger children, and short- and long-term morbidity. Further advances are required in the prevention and early recognition of GAS disease. The online version contains supplementary material available at 10.1007/s00431-022-04718-y.
登录
查看更多内容
影响因子:
36.4
作者:
Agyeman, Philipp K. A.;Schlapbach, Luregn J.;Berger, Christoph
通讯作者:
Berger, Christoph
影响因子:
2.4
作者:
Feudtner C;Feinstein JA;Zhong W;Hall M;Dai D
通讯作者:
Dai D
影响因子:
8
作者:
Laupland, KB;Davies, HD;McGeer, A
通讯作者:
McGeer, A
影响因子:
36.4
作者:
Martinon-Torres, Federico;Salas, Antonio;Levin, Michael
通讯作者:
Levin, Michael
影响因子:
8
作者:
Odetola, Folafoluwa O.;Gebremariam, Achamyeleh;Freed, Gary L.
通讯作者:
Freed, Gary L.